Michelsen Christopher MD is categorized under Orthopedic Doctors and Physicians in New York City, NY and active since 1986.
Michelsen Christopher MD was established in 1986, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Orthopedic Doctors and Physicians business, which does work in the B2C market, and is classified as a Orthopedic Doctors and Physicians, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Christopher Michelsen at the company’s single location by writing to 5141 Broadway, New York City, New York NY 10034 or by phoning (212) 932-4403. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Michelsen Christopher MD |
Contact Person: | Christopher Michelsen |
Address: | 5141 Broadway, New York City, New York 10034 |
Phone Number: | (212) 932-4403 |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 1986 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Orthopedic Doctors and Physicians |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Michelsen Christopher MD was started in 1986 to provide professional Orthopedic Doctors and Physicians under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Christopher Michelsen for inquiries that concern Michelsen Christopher MD by calling the company number (212) 932-4403, as your correspondence is most welcome. Additionally, the physical location of the single location of Michelsen Christopher MD can be found at the coordinates 40.87283,-73.91229 as well as the street address 5141 Broadway in New York City, New York 10034.
For its online presence, you may visit Michelsen Christopher MD’s website at and engage with its social media outlets through on Twitter and on Facebook.